Trinity Biotech Plc (TRIB)
6.11
-0.64
(-9.48%)
USD |
NASDAQ |
Oct 08, 15:58
Trinity Biotech Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -71.98M |
| September 30, 2025 | -54.72M |
| June 30, 2025 | -49.54M |
| March 31, 2025 | -43.62M |
| December 31, 2024 | -35.18M |
| September 30, 2024 | -26.34M |
| June 30, 2024 | -29.40M |
| March 31, 2024 | -22.86M |
| December 31, 2023 | -23.95M |
| September 30, 2023 | -17.49M |
| June 30, 2023 | -11.38M |
| March 31, 2023 | -6.618M |
| December 31, 2022 | -2.176M |
| September 30, 2022 | 6.633M |
| June 30, 2022 | 15.82M |
| March 31, 2022 | -6.285M |
| December 31, 2021 | -0.319M |
| September 30, 2021 | 0.81M |
| June 30, 2021 | -0.496M |
| March 31, 2021 | -0.127M |
| December 31, 2020 | -2.219M |
| September 30, 2020 | 7.071M |
| June 30, 2020 | -0.712M |
| March 31, 2020 | 0.768M |
| December 31, 2019 | 4.713M |
| Date | Value |
|---|---|
| September 30, 2019 | 38.93M |
| June 30, 2019 | 39.07M |
| March 31, 2019 | 44.17M |
| December 31, 2018 | 44.05M |
| September 30, 2018 | 68.08M |
| June 30, 2018 | 66.69M |
| March 31, 2018 | 65.78M |
| December 31, 2017 | 65.20M |
| September 30, 2017 | 106.39M |
| June 30, 2017 | 106.87M |
| March 31, 2017 | 109.28M |
| December 31, 2016 | 109.33M |
| September 30, 2016 | 210.40M |
| June 30, 2016 | 210.66M |
| March 31, 2016 | 212.47M |
| December 31, 2015 | 213.89M |
| September 30, 2015 | 211.00M |
| June 30, 2015 | 205.06M |
| March 31, 2015 | 201.24M |
| December 31, 2014 | 191.04M |
| September 30, 2014 | 187.30M |
| June 30, 2014 | 196.11M |
| March 31, 2014 | 189.01M |
| December 31, 2013 | 183.01M |
| September 30, 2013 | 175.13M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 41.07M |
| Akari Therapeutics Plc | 18.60M |
| Autolus Therapeutics Plc | 74.84M |
| Evaxion AS | 9.531M |
Shareholders Equity (Quarterly) Related Metrics
| Debt to Equity Ratio | -1.917 |
| Current Ratio | 0.2542 |
| Net Debt Paydown Yield | 192.2% |